APRILBIO Co., Ltd announced that it has received KRW 10,000,000,000 in a funding from returning investor, Yuhan Corporation on March 23, 2021. As a part of transaction the investor acquired 13.76% stake in the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,530 KRW | +5.22% | +0.32% | -7.83% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.83% | 250M | |
+8.59% | 114B | |
+10.80% | 104B | |
-12.90% | 22.41B | |
-1.19% | 22.28B | |
-5.24% | 19.07B | |
-38.29% | 18B | |
-5.05% | 17.89B | |
+7.57% | 14.28B | |
+35.84% | 12.55B |
- Stock Market
- Equities
- A397030 Stock
- News AprilBio Co.,Ltd.
- APRILBIO co., Ltd. announced that it has received KRW 10 billion in funding from Yuhan Corporation